Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Arena Pharmaceuticals Inc buy Maxi_Scalibusa

Start price
€45.79
22.02.19 / 50%
Target price
€135.30
04.11.21
Performance (%)
19.03%
End price
€54.50
05.11.21
Summary
This prediction ended on 05.11.21 with a price of €54.50. The prediction had a final performance of 19.03%. Maxi_Scalibusa has 50% into this prediction

Arena Pharmaceuticals, Inc. (Symbol ARNA) is a biopharmaceutical company based in San Diego, California that focuses on the research, development, and commercialization of novel medications. The company's primary focus is on developing small molecule drugs that target G protein-coupled receptors, which are involved in a wide range of physiological processes. Arena has a diverse pipeline of potential drug candidates in various stages of development, including treatments for pulmonary arterial hypertension, pain, autoimmune diseases, and more. The company's stock is listed on the NASDAQ exchange and is widely considered to be a high-risk/high-reward investment.

Performance without dividends (%)
Name 1w 1m 1y 3y
Arena Pharmaceuticals Inc - - - -
iShares Core DAX® 1.080% -2.131% 14.264% 15.290%
iShares Nasdaq 100 0.362% 7.059% 35.383% 56.103%
iShares Nikkei 225® -1.155% -0.483% 8.258% 4.324%
iShares S&P 500 0.806% 5.037% 29.635% 49.529%

Comments by Maxi_Scalibusa for this prediction

In the thread Arena Pharmaceuticals Inc diskutieren
Prediction Buy
Perf. (%) 19.03%
Target price 135.300
Change
Ends at 04.11.21

Arena Pharma

In the thread Trading Arena Pharmaceuticals Inc
Prediction Buy
Perf. (%) 19.03%
Target price 135.300
Change
Ends at 04.11.21

Die von Maxi_Scalibusa gewählte maximale Laufzeit wurde überschritten